Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 20/20 | 0.80 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.73 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14645829 | 0.89 | HDAC4 (1.00) | HDAC4HDAC6HDAC1 | |
| SCHEMBL19668121 | 0.85 | HDAC4 (0.80) | HDAC4HDAC6HDAC1 | |
| SCHEMBL18921045 | 0.85 | HDAC4 (0.80) | HDAC4HDAC6HDAC1 | |
| SCHEMBL20838117 | 0.84 | HDAC4 (0.83) | HDAC4HDAC6HDAC1 | |
| SCHEMBL14645749 | 0.84 | HDAC4 (1.00) | HDAC4HDAC6HDAC1 | |
| SCHEMBL14645880 | 0.84 | HDAC4 (1.00) | HDAC4HDAC6HDAC1 | |
| SCHEMBL14645750 | 0.84 | HDAC4 (1.00) | HDAC4HDAC6HDAC1 | |
| SCHEMBL21900300 | 0.84 | HDAC4 (0.72) | HDAC4HDAC6HDAC1 | |
| SCHEMBL21038216 | 0.83 | HDAC4 (0.81) | HDAC4HDAC6HDAC1 | |
| SCHEMBL14645693 | 0.83 | HDAC4 (1.00) | HDAC4HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11206831-B2 | Substituted oxadiazoles for combating phytopathogenic fungi | BASF SE (DE) | 2021-12-28 | — | — | US | disclosed |
| EP-3383180-B1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2021-07-21 | — | — | EP | disclosed |
| US-20200281204-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2020-09-10 | — | — | US | disclosed |
| EP-3383180-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017093019-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11206831-B2 | Substituted oxadiazoles for combating phytopathogenic fungi | CYP51A1, OSR1, FOXO3 | HDAC4 2408/4885HDAC6 447/4885HDAC1 1331/4885 |
| US-20200281204-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | CYP51A1, OSR1, FOXO3 | HDAC4 2408/4885HDAC6 447/4885HDAC1 1331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.